PCPeranut Chotcomwongse

Peranut Chotcomwongse

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Peranut Chotcomwongse has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Predicting diabetic macular edema treatment responses using OCT: Dataset and methods of APTOS competition

    by Weiyi Zhang, Peranut Chotcomwongse, Yinwen Li, Pusheng Xu, Ruijie Yao, Lianhao Zhou, Yuxuan Zhou, Hui Feng, Qiping Zhou, Xinyue Wang, et al.


  • Predictors of persistent central serous chorioretinopathy: a multicenter retrospective study – MICRoN report number four

    by Priyanka Gandhi, Nasiq Hasan, Korrina Gidwani, Jonathan Yang, Jessica Cao, Stanley Saju, Charles C. Wykoff, Samer Khateb, Min Kim, Ninan Jacob, et al.

    Purpose While central serous chorioretinopathy (CSCR) frequently resolves after the first episode, in 30–50% of cases, subretinal fluid (SRF) persists and can substantially impair vision. To identify persistence predictors, this study compared demographic, clinical, and imaging data between patients with resolution and SRF persistence. Methods Retrospective data were collected at baseline and follow-up from 308 eyes of 295 patients with CSCR in collaboration with the Macula Society CSCR Study Group. Patients were divided into a resolved (RG) and a persistent CSCR group (PG). Patients with known recurrence after resolution were excluded. Optical coherence tomography (OCT) biomarkers including central macular thickness (CMT), subfoveal choroidal thickness (SFCT), neurosensory detachment height (NSD), Haller layer thickness, inner choroidal thickness (ICT), and choroidal vascularity index (CVI) were analysed. Results PG had 148 eyes and RG had 160 eyes. Mean age in PG vs RG was 47.62 ± 11.63 vs. 44.89 ± 10.12 years (p = 0.029). Mean presenting symptom duration was significantly greater in PG than RG (8.67 ± 23.33 vs. 4.33 ± 31.18 months) (p = 0.005). There was a higher frequency of complex cases (21.6%) in PG (p < 0.001). Baseline mean CMT (358.11 ± 157.02 microns) and NSD height (175.78 ± 134.34 microns) were significantly lower in PG (p = 0.007). Multivariate logistic regression analysis showed that each additional year of age was associated with a 22.3% increase in the odds of having persistent SRF. Conclusion Age at presentation, symptom duration, baseline CMT and NSD height may serve as practical risk stratifiers to identify eyes at high risk for chronicity in CSCR. Key messages What is known Delayed presentation and absence of early therapy predispose eyes to chronic CSCR. SFCT plays a predictive role in persistent CSCR. What is new Age at presentation is a significant predictor of persistent SRF. Baseline CMT and NSD height may serve as practical risk stratifiers to identify eyes at high risk for chronicity.


  • Open Access

    Revisiting the Role of Intravitreal Triamcinolone in Diabetic Macular Edema: 12-Month Outcomes after Bevacizumab Failure

    by Sukhum Silpa-Archa, Variya Nganthavee, Peranut Chotcomwongse, Pawas Lalitwongsa, Paisan Ruamviboonsuk

    Introduction Refractory diabetic macular edema (DME) is challenging in resource-limited settings, where costly alternatives such as non-bevacizumab anti-vascular endothelial growth factors (VEGFs) and corticosteroid implants are inaccessible. In Thailand, budget constraints exclude these drugs from healthcare schemes covering 92% of the population, a common issue in developing Asian countries. Therefore, this study aimed to evaluate the treatment outcome of repeated intravitreal triamcinolone acetonide (IVTA) dosages for DME refractory to intravitreal bevacizumab over a 12-month period using a decision algorithm. Methods This was a comparative retrospective study. The included patients were randomly divided into two groups that received either 2 mg or 4 mg IVTA, following a decision algorithm. The primary outcome was the difference in central macular thickness (CMT) between the 2 mg IVTA and 4 mg IVTA groups at 6-month and 12-month follow-up visits. Results Overall, 81 eyes (62 patients) with DME refractory to bevacizumab were enrolled. The study involved 53 eyes (37 cases) divided into two groups: group 1 (2 mg IVTA) of 14 eyes, and group 2 (4 mg IVTA) of 39 eyes. The 4 mg IVTA group had a higher initial CMT than their 2 mg IVTA counterparts (P = 0.02). This difference disappeared after 6 and 12 months. The improvement in CMT in both groups was maintained across the 6- and 12-month follow-up periods compared with baseline. Univariate logistic regression analysis revealed that patients with thinner CMT before IVTA treatment had a greater probability of being DME-free over long-term follow-up. Conclusions Repeated IVTA treatments for DME refractory to bevacizumab over a 12-month period demonstrated efficacy and appeared to have a comparable safety profile. Patients with thinner CMT before IVTA treatment had a greater probability of remaining DME-free after IVTA treatment.


  • Open Access

    Influence of Different Types of Retinal Cameras on the Performance of Deep Learning Algorithms in Diabetic Retinopathy Screening

    by Ramyaa Srinivasan, Janani Surya, Paisan Ruamviboonsuk, Peranut Chotcomwongse, Rajiv Raman

    Background: The aim of this study was to assess the performance of regional graders and artificial intelligence algorithms across retinal cameras with different specifications in classifying an image as gradable and ungradable. Methods: Study subjects were included from a community-based nationwide diabetic retinopathy screening program in Thailand. Various non-mydriatic fundus cameras were used for image acquisition, including Kowa Nonmyd, Kowa Nonmyd α-DⅢ, Kowa Nonmyd 7, Kowa Nonmyd WX, Kowa VX 10 α, Kowa VX 20 and Nidek AFC 210. All retinal photographs were graded by deep learning algorithms and human graders and compared with a standard reference. Results: Images were divided into two categories as gradable and ungradable images. Four thousand eight hundred fifty-two participants with 19,408 fundus images were included, of which 15,351 (79.09%) were gradable images and the remaining 4057 (20.90%) were ungradable images. Conclusions: The deep learning (DL) algorithm demonstrated better sensitivity, specificity and kappa than the human graders for all eight types of non-mydriatic fundus cameras. The deep learning system showed, more consistent diagnostic performance than the human graders across images of varying quality and camera types.


  • Spontaneous Resolution of Subretinal Fluid Secondary to Retinal Astrocytic Hamartoma in Tuberous Sclerosis:A Case Report

    by Atchara Amphornphruet, Peranut Chotcomwongse, Kumphol Yimrattananuwat, Philip Ferrone

    Retinal astrocytic hamartoma is the most common ocular manifestation in tuberous sclerosis. Although astrocytic hamartomas are usually benign and stationary, there are occasionally circumstances when they are considered to be active. In this study, the authors report a case of self-limited visual impairment due to astrocytic hamartomas. [ Ophthalmic Surg Lasers Imaging Retina. 2019;50:737–739.]